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The zebraﬁsh has proven to be an excellent model for human disease, particularly hematopoietic diseases, since these ﬁsh
make similar types of blood cells as humans and other mammals. The genetic program that regulates the development and
diﬀerentiation of hematopoietic cells is highly conserved. Hematopoietic stem cells (HSCs) are the source of all the blood cells
needed by an organism during its lifetime. Identifying an HSC requires a functional assay, namely, a transplantation assay
consisting of multilineage engraftment of a recipient and subsequent serial transplant recipients. In the past decade, several
types of hematopoietic transplant assays have been developed in the zebraﬁsh. An understanding of the major histocompatibility
complex (MHC) genes in the zebraﬁsh has lagged behind transplantation experiments, limiting the ability to perform unbiased
competitive transplantation assays. This paper summarizes the diﬀerent hematopoietic transplantation experiments performed in
thezebraﬁsh,bothwithandwithoutimmunologicmatching,anddiscussesfuturedirectionsforthispowerfulexperimentalmodel
of human blood diseases.
1.Introduction
In the past few decades, the zebraﬁsh has emerged as an
outstanding vertebrate animal model for studying develop-
mental hematopoiesis (reviewed in [1, 2]). In this same time
frame, the understanding of the biology of adult hematopoi-
etic stem cells has also blossomed, predominantly due to
hematopoietic transplantation experiments performed in
mice(reviewedbyOrkinandZonin[3]).Tocapitalizeonthe
advantagesof the zebraﬁshmodel (smallsize, high fecundity,
rapid maturation, external fertilization, and the ability to
perform large-scale genetic and chemical screens), a zebra-
ﬁsh hematopoietic transplantation assay was needed.
Developing a transplantation assay in the zebraﬁsh
required a diﬀerent approach than that used in mice. While
diﬀerential expression of CD45 isoforms is generally used
to distinguish between donor and recipient cells in murine
transplant assays, these reagents are not available for
zebraﬁsh. Instead, scientists have utilized transgenic technol-
ogy to make zebraﬁsh expressing green ﬂuorescent protein
(GFP) or other ﬂuorochromes under the inﬂuence of an
ubiquitous or a tissue-speciﬁc promoter. These ﬂuorescently
labeled donor cells are transplanted into ﬂuorochrome-
negative recipients, and engraftment is monitored at various
time points after transplant.
2. A History of Hematopoietic
TransplantationinZebraﬁsh
2.1. Adult Marrow Cells into Embryos. The ﬁrst hematopoi-
etic transplant experiments in zebraﬁsh were performed by
Traver et al., whose work was published in 2003 [4]. This
landmark paper was the ﬁrst to report the evaluation of
zebraﬁsh kidney marrow cells including separation of the
major blood cell lineages by ﬂow cytometry, a method which2 Advances in Hematology
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Figure 1: Flow cytometry analysis of zebraﬁsh whole kidney marrow from a marrow transplant recipient. Zebraﬁsh transplant recipients
were irradiated and injected with 5 × 105 marrow cells from a transgenic β-actin:GFP donor. Whole kidney marrow from a representative
recipient was dissected 3 months later and analyzed by ﬂow cytometry. (a) The forward scatter (FSC) versus side scatter (SSC) proﬁle of
zebraﬁsh whole kidney marrow shows four cell populations: erythroid, lymphoid, myeloid, and precursor cells. (b) Histograms for GFP
expression of cells within the lymphoid, myeloid and precursor gates show multilineage engraftment with GFP+ donor cells (blue lines). The
red lines show GFP expression in a wild-type-negative control ﬁsh.
is currently the standard procedure for identifying multi-
lineage engraftment after hematopoietic transplantation in
zebraﬁsh (Figure 1(a)). In addition, hematopoietic trans-
plantation was used to rescue two diﬀerent mutant embryos.
The Vlad tepes (gata1−/−)m u t a t i o ni sh o m o z y g o u sl e t h a l
by 14 days after fertilization, and these embryos have a
complete absence of erythroid cells [5]. Approximately 100–
1000 whole kidney marrow (WKM) cells from a gata1-
GFP transgenic donor were injected into the circulation of
gata1−/− zebraﬁshembryos48hoursafterfertilization(hpf).
While untransplanted control embryos did not survive past
14 dpf, 20–60% of the transplant recipients survived long
term,upto8monthsaftertransplant.Allsurvivingrecipients
had circulating GFP+ red blood cells, indistinguishable from
the gata1-GFP donors [4].
Taking these embryonic transplant experiments one step
further, donor marrow was isolated from double transgenic
β-actin-GFP/gata1-dsRED ﬁsh, in order to monitor donor-
derived cells from multiple lineages. The β-actin-GFP trans-
gene is expressed by almost all zebraﬁsh cell types, including
all leukocytes. Erythrocytes do not express βactin, so they
are marked by the gata1-dsRED transgene instead. For these
experiments, the transplant recipients were bloodless (bls)
mutants, a dominant, partially penetrant mutation resulting
in absent primitive hematopoiesis, but preserved adult
hematopoiesis [6]. Injection of double-positive WKM cells
into 48hpf bls mutants allowed independent tracking of
GFP+ leukocytes and dsRED+ erythrocytes in the recipient
embryos [4]. Sustained multilineage donor-derived cells
were visible in the circulation of transplant recipients at
8 weeks after transplantation, indicating successful engraft-
ment of long-term hematopoietic repopulating cells.
2.2. Adult Marrow Cells into Adult Recipients. Following up
on their transplantation experiments into embryos, Traver
et al. subsequently performed transplantation of WKM
cells into adult recipients [7]. After using ionizing radia-
tion as pretransplant conditioning to ablate the recipient’s
hematopoietic cells, including the immune system, approx-
imately 1 × 106 β-actin-GFP/gata1-dsRED donor marrowAdvances in Hematology 3
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Figure 2: Direct visualization of engrafted GFP+ and mCherry+ marrow donor cells in casper recipients. 40 × 103 WKM cells from a
transgenic ubiquitin:GFP donor were mixed with 80 × 103 WKM cells from a transgenic ubiquitin:mCherry donor and injected into the
circulationofacasper recipientﬁsh.Thephotosaretaken4weeksaftertransplantationandshowengraftmentof(a)GFP+ and(b)mCherry+
cells in the kidney (white arrows).
cells were delivered into the recipient’s circulation by direct
intracardiac injection. When irradiated with 40Gy, a lethal
dose, all the untransplanted animals died by 14 days after
irradiation. However, >70% of the animals receiving WKM
cells after irradiation were rescued, and survived at least 30
days after irradiation. As in the experiments with embry-
onic transplant recipients, GFP+ leukocytes and dsRED+
erythrocytes were visible in the circulation of the engrafted
adult recipients using ﬂuorescence light microscopy [7].
FACS analysis of recipient WKM showed robust multilineage
engraftment with >86% GFP+ cells up to 8 weeks after
transplant (Figure 1(b)).
2.3. Embryonic HSCs into Embryos. Similar to murine embr-
yonic HSCs, the ﬁrst HSCs in the developing zebraﬁsh are
located in the aorta-gonad-mesonephros (AGM) [8]. Initial
experiments to identify these HSCs in zebraﬁsh relied upon
anatomic similarities with murine embryonic HSCs. Cells
expressingcmyb,runx1,andCD41areobservedintheventral
wall of the dorsal aorta in zebraﬁsh embryos 24–36hpf
[9–12], similar to the expression noted in the ventral wall
of the aorta in murine embryos [13]. These cmyb+a n d
runx1+ cells were presumed to be embryonic deﬁnitive
HSCs, although functional evaluation of these cells was
lacking. Using CD41 as another marker of embryonic HSCs,
Bertrand et al. sorted CD41+/gata1− donor cells by ﬂow
cytometry from CD41-eGFP/gata1-dsRED double transgenic
embryos at 72hpf [14]. These cells were then injected into
thesinusvenosusofage-matchedwild-typeembryos.Within
one day after transplant, donor-derived cells were observed
in the caudal hematopoietic tissue (CHT) and thymi of
recipients. Although the transplanted donor cells had been
dsRED negative, subsequent erythroid diﬀerentiation of
engrafted cells revealed dsRED+ cells in the circulation of
recipients [14]. These experiments helped to prove that
CD41+ cells in the AGM are capable of colonizing deﬁnitive
hematopoietic organs, namely, the thymus and CHT, in
developing zebraﬁsh, and therefore, this population includes
the ﬁrst developing HSCs in the embryo.
2.4.ACompetitiveTransplantationAssayforChemicalScreen-
ing. Capitalizing on the relative ease of in vivo chemical
screening using the zebraﬁsh model, Li et al. have utilized
a competitive hematopoietic transplantation assay to search
for chemicals that enhance hematopoietic engraftment
(manuscript submitted). Marrow cells from βactin-GFP ﬁsh
were incubated ex vivo in chemicals from a panel of more
than 2000 known bioactive compounds. After pretreatment,
the βactin-GFP WKM was mixed at a standard ratio with
WKM from commercially available red Gloﬁsh, and trans-
planted into casper recipient ﬁsh [15]. Normally kidney
marrow ﬂuorescence is not visible in an adult animal due to
thepresenceofpigmentationintheskin.However,casperﬁsh
are homozygous for two pigment mutations, roy and nacre,
and therefore have transparent skin, allowing visualization
of engrafted ﬂuorescent marrow cells in vivo. Unlike prior
studies examining engraftment at a single time point by
FACS analysis of multilineage WKM populations, this screen
also followed the level of GFP+ and RFP+ cells in the
kidney of anesthetized recipients at several time points after
transplant (Figure 2). The ratio of green:red marrow cells
by ﬂuorescence microscopy in vivo was highly correlated
with the green:red ratio measured by ﬂow cytometry of
the dissected WKM cell preparation. All chemicals identiﬁed
in the screen that stimulated enhanced engraftment were
also tested in murine transplants to validate the eﬀects in
an immune-matched mammalian transplant assay. In total,
ten compounds were identiﬁed in the screen that resulted in
enhanced green:red ratio, and these are currently undergo-
ing further evaluation.
3. Importance of Immune Matching
inHematopoietic Transplantation
None of the transplantation experiments described to this
point took into account any aspect of immunologic match-
ing, as isogenic and congenic ﬁsh lines were not available.
This fact highlights another signiﬁcant diﬀerence between
murine and zebraﬁsh marrow transplants, namely that mu-
rine donors and recipients are congenic and hence immuno-
logically identical. In contrast, although many commonly
used zebraﬁsh lines (e.g., AB, Tubingen, and wik) have
been repeatedly incrossed through decades of laboratory use,
attempts to generate truly isogenic or congenic zebraﬁsh
lines have largely failed due to inbreeding depression such
that these ﬁsh lines could no longer be maintained [16]. In
addition, sex skewing of clutches, whereby a generation of
siblings was all the same sex, has also hindered the ability4 Advances in Hematology
to maintain highly inbred ﬁsh lines. Despite this disadvan-
tage, signiﬁcant progress has still been made developing
hematopoietic transplantation methods in the zebraﬁsh over
the past decade, as described above.
As more sophisticated transplantation experiments are
designedtoaskmorecomplexquestionsaboutstemcellbiol-
ogy, the need for immune matching becomes more critical.
When transplanting any allogeneic tissue into an adult recip-
ient with a competent immune system, one would expect a
lack of immune matching to result in rejection of the trans-
planted tissue (reviewed in [17]). In the zebraﬁsh, immune
matching is not required in embryonic recipients younger
than 5 days after fertilization, as thymic development is not
apparent until then [18]. By 4–6 weeks after fertilization, the
cellular and humoral immune system is fully functional and
would be capable of rejecting any transplanted tissue that
wasnothistocompatible[19,20].Pretransplantconditioning
with radiation is commonly used to suppress the immune
system of adult murine and zebraﬁsh recipients, and in the
case of hematopoietic transplants to give the added advan-
tage of clearing the marrow niche. For zebraﬁsh recipients
receiving a sublethal dose of radiation, the transplanted
tissue is still rejected once the recipient’s immune cells
recover, approximately 4 weeks after irradiation [21].
Another consequence of immune mismatch between
transplant donors and recipients occurs uniquely in the
setting of hematopoietic transplantation. When engrafted
immune cells recognize the recipient as “nonself,” an im-
mune response is mounted against the recipient’s tissues
resulting in graft-versus-host disease (GVHD), a phenome-
non that is also observed clinically in human allogeneic
bone marrow transplant [22]. Therefore, the importance of
immune matching in hematopoietic transplantation impacts
not only initial engraftment, but also the health and survival
of the recipient if the engrafted hematopoietic cells attack the
host.
4.Methods to Quantitate
Hematopoietic Engraftment
Comparing the function of two HSC populations involves a
competitive hematopoietic transplantation assay where both
populations engraft in the same transplant recipient
(reviewedbyPurtonandScaddenin[23]).Thisexperimental
designisrequiredwhenmutantmarrowcellsfromonedonor
are hypothesized to have defective hematopoietic engraft-
ment. The mutant cells are transplanted into the recipient
together with a radio-protective dose of wild-type marrow
cells. If the mutant HSCs are defective, the wild-type HSCs
will out-compete them, and the donor chimerism of the
recipient will highly favor the wild-type donor cells. Without
these wild-type HSCs to rescue the recipient, lack of engraft-
ment of the mutant cells would likely result in the recipient’s
death, and there would be no blood or marrow cells to
evaluate at the end of the experiment. Using a competitive
experimental design ensures that all the recipients survive
until the end of the experiment and their data are included
in theﬁnalanalyses.In the eventthatthe mutantmarrow has
normal HSC function, the donor chimerism would reveal
an equal mix of engrafted hematopoietic cells from both
donors. Immune matching of both donors and the recipient
is an essential component of any competitive hematopoietic
transplantation assay. Otherwise, one cannot rule out biased
immune rejection of one donor’s cells compared to the
other, and the engraftment “winner” may merely reﬂect
immunologic diﬀerences and not a diﬀerence in stem cell
biology.
A variation of the competitive hematopoietic transplan-
tation assay is the limit dilution assay. This method is the
goldstandardforquantitatingHSCcontentandalsorequires
all donors and recipients to be immunologically matched.
Thisassayinvolvestransplantationofseriallydilutedmarrow
cells such that fewer and fewer marrow cells are given to
subsequent transplant recipients, while a constant number
of wild-type marrow cells are given simultaneously to radio-
protect the recipients. Engraftment and donor chimerism
are evaluated for each recipient, and then Poisson statistics
are used to calculate the number of long-term repopulating
cells contained in the original marrow population [24]. The
ability to perform these competitive and quantitative exper-
iments using zebraﬁsh HSCs will be essential to characterize
stem cell mutants and asking questions about HSC biology.
Therefore, a better understanding of the histocompatibility
genes in the zebraﬁsh is needed so that these assays can be
performed with proper immune matching.
5. HistocompatibilityAntigens in Zebraﬁsh
Compared with Other Vertebrates
Oneoftheﬁrstmultimegabaseregionsofthehumangenome
to be sequenced, the human major histocompatibility com-
plex (MHC) locus, is located on chromosome 6p21.31 and
containsover200identiﬁedgeneswithina3.6 ×106 basepair
span [25]. The classical class I and class II genes within the
MHC region are the central cell surface proteins responsible
fordeterminingtissuehistocompatibilityofanallograft.This
gene-dense region also contains a number of other genes
important for the immune response, including antigen-
processing genessuch as proteasome subunitβ type(PSMB),
complement genes, and the peptide transporters TAP1 and
TAP2 [26, 27].
ClassIMHCmoleculesarepolymorphictransmembrane
proteins with three immunoglobulin-like domains that are
expressed on virtually all cell types. They bind noncovalently
to β2-microglobulin and present endogenously derived pep-
tides to CD8+ Tl y m p h o c y t e s( r e v i e w e di n[ 28]). Although
class I and II proteins share a similar three-dimensional
structure, class II MHC molecules are heterodimeric com-
plexes consisting of an alpha chain and a beta chain, with
each chain containing two immunoglobulin-like domains.
They present lysosomally derived peptide antigens to CD4+
T lymphocytes, and their expression is limited to B-lympho-
cytes, macrophages, and other antigen-presenting cells.
While most jawed vertebrate species possess linked class
I and II genes located within a single chromosomal locus
similar to the human MHC, the bony ﬁshes are unique inAdvances in Hematology 5
Table 1: Mean percentage of GFP+ cells in engrafted recipient zebraﬁsh receiving MHC-matched or -unmatched donor marrow.
Only Chr 19 matched [35] Chr 1, 8, 19 all matched
Myeloid matched 47.86 ±30.9 P = 0.0002 52.36 ±25.43 P = 0.0036
Myeloid unmatched 6.45 ±1.77 11.58 ±7.03
Lymphoid matched 10.51 ±19.88 P = 0.05 9.51 ±12.32 P = 0.047
Lymphoid unmatched 1.28 ±0.38 3.47 ±4.601
Data are mean ± S.D.
that they have class I and II genes located on distinct chro-
mosomes [29]. In the zebraﬁsh, at least three relevant loci
have been identiﬁed. Chromosome 19 contains class I genes
as well as some antigen-processing genes, making the locus
syntenic to the human MHC locus [30, 31]. However, there
arenoclassIIgenesonchromosome19.Insteadthezebraﬁsh
class II alpha and beta genes are located on chromosome 8
[26, 32]. Chromosome 1 contains additional class I genes,
termed“ze”genes,whichappearmostsimilartomammalian
nonclassical Class I genes [33]. Finally, the “L” genes, class
I genes unique to teleost ﬁsh, are located on chromosomes
3 and 8, although they are less polymorphic than other
class I genes, and their precise function is not clear [34].
While DNA sequence analyses of the zebraﬁsh MHC genes
show similarities with MHC genes of many species, virtually
no data are available to evaluate the function or even the
cell-surface expression of the class I and II genes in zebraﬁsh.
Prior to the transplantation experiments described below, no
functional evaluation of any zebraﬁsh MHC genes had been
performed.
6. Immune-MatchedHematopoietic
TransplantsinZebraﬁsh
Following up on the adult marrow transplant experiments
published in 2004 [7], subsequent adult transplantation
experiments sought to evaluate long-term hematopoietic
engraftment greater than 12 weeks after transplant. Hav-
ing observed poor survival in random donor long-term
hematopoietic transplantation experiments (J. L. O. de Jong
and L. I. Zon, unpublished data), immune typing of the
zebraﬁsh MHC genes was a logical step to ensure that
graft rejection and/or GVHD were not contributing to the
recipient mortality. In these ﬁrst hematopoietic transplant
experiments with immune matching, the class I MHC
genes at the chromosome 19 locus were typed for all the
sibling progeny of a single mating pair [35]. Genotyping
was achieved by preparing DNA from ﬁn clips of individ-
ual ﬁsh, then using a panel of PCR primers to amplify
MHC gene sequences. The ampliﬁed fragments were then
sequenced to identify the speciﬁc MHC genes present in
each individual animal. As expected, there were four MHC
haplotypesrepresentedwithinthisfamily,andapproximately
25% of the progeny fell into each of the four genotypes.
WKM cells from β-actin-GFP+ donor ﬁsh of each MHC
genotype were transplanted into GFP-negative siblings of
the same MHC genotype and also into unrelated wild-
type recipients, presumed to be mismatched. Survival and
donorchimerismweresigniﬁcantlyimprovedinthematched
recipients compared with the unmatched recipients (Table
1), indicating the importance of immune matching at the
chromosome 19 MHC locus for hematopoietic engraftment
[35]. These experiments were the ﬁrst functional evaluation
of any zebraﬁsh MHC genes in a transplantation assay.
These ﬁrst experiments did not speciﬁcally type for class
II genes located on chromosome 8, or other class I genes on
other chromosomes. It may be that coincidental matching at
the class II locus occurred for a signiﬁcant number of the
related “matched” recipients in these experiments, thereby
contributing to improved donor chimerism.
We expected that immune matching at the class II locus
would also be important for hematopoietic engraftment.
Therefore, we performed additional transplantation exper-
iments matching the donors and recipients at three separate
loci: the two class I loci on chromosomes 1 and 19 and the
class II locus on chromosome 8. 2.5 × 105 WKM cells from
β-actin-GFP+ donor ﬁsh were transplanted into both com-
pletely matched recipients and unmatched, unrelated recip-
ients. Long-term engraftment at 3 months after transplant
showed similar donor chimerism results as the transplant
experimentswithmatchingatonlythechromosome19locus
(Table 1). These data suggest that matching of the class I
genes at the chromosome 19 locus is the most important
for tissue histocompatibility in a transplantation assay, and
that the additional MHC loci on chromosomes 1 and 8
play a minimal role. Further experiments are underway to
individually test the class I genes on chromosome 1 and the
class II genes on chromosome 8 to determine the contrib-
ution, if any, of these loci to histocompatibility in tissue
transplantation.
7. OptimizingSurvivalof Hematopoietic
TransplantRecipients
Survival of zebraﬁsh hematopoietic transplant recipients is
often diﬃcult to predict from one experiment to the next.
We have implemented a number of changes to the initially
published transplantation protocol to address the problem
of poor survival after transplant. While lack of histocom-
patibility may play a role for some animals, a number of
other factors also appear to be important. In our experience,
younger ﬁsh have better survival than older ﬁsh, and optimal6 Advances in Hematology
recipients are approximately 3-4 months of age (J. L. O. de
Jong and L. I. Zon, unpublished data). This may be due to
colonization of older ﬁsh with bacterial or fungal pathogens
that overwhelm and kill the immune-compromised host
after transplantation. Maintaining excellent water quality is
also critically important to recipient survival. We hypothe-
sized that treatment with prophylactic antibiotics for a few
days immediately after transplant might improve survival.
However, placing transplant recipients “oﬀ system” in ﬁsh
water containing antibiotics paradoxically caused decreased
survival, as ﬁsh being treated in this way suﬀered from
quickly deteriorating water quality and high ammonia
levels (C. Lawrence, personal communication). While it is
impractical to keep a therapeutic level of antibiotics in the
large volume of water circulating through an entire aquatic
system, the ability to maintain water quality at a consistently
highstandardresultedinimprovedsurvivalofourtransplant
recipients, even without antibiotics.
Determining the appropriate radiation dose for pre-
transplant conditioning of recipient ﬁsh has also proven
morechallengingthaninitially anticipated. Watercangreatly
attenuate the radiation dose over a short distance. For exam-
ple, at a depth of 1cm of water, we have observed that the
radiationdoseatthebottomofthedishisdecreasedbyabout
10–15% compared with the radiation dose at the surface of
the water (J. L. O. de Jong, unpublished data). Therefore,
it is critically important that ﬁsh be placed in a minimal
volume and depth of water to ensure that all recipients
receive an equivalent radiation dose. The minimum lethal
dose of radiation for zebraﬁsh was ﬁrst reported to be 40Gy
[7].However,subsequentworkshowedthatthisdosewasnot
optimal for pretransplant conditioning, as the mortality of
ﬁsh was 100%, even after receiving a radio-protective dose of
WKM cells. A sublethal dose of 25Gy provided for maximal
survival with engraftment, so this was the dose selected for
most experiments [35]. This result suggests that while the
hematopoietic compartment is the most radiation-sensitive
tissue in the zebraﬁsh, as in mammals, there is a narrow
therapeutic index for lethal radiation damage to other tis-
sues. To minimize the radiation injury to nonhematopoietic
tissues, many protocols for murine and human bone marrow
transplants utilize fractionated radiation dosing. We have
now initiated a standard conditioning protocol of 30Gy
split into two equal fractions of 15Gy, where the two
fractions are given 24 hours apart. The survival of these
recipients is comparable to animals receiving 25Gy as a
single dose (J. L. O. de Jong, unpublished data). Finally,
we have observed that diﬀerent ﬁsh lines have varying
sensitivities to radiation. For example, when comparing ﬁsh
from the AB strain that have been bred to homozygosity
at the MHC loci, some were signiﬁcantly more sensitive to
a given radiation dose than others (Figure 3). This result
suggests that a radiation dose-response titration should be
performed for each strain of recipients to be transplanted in
order to determine the optimal radiation dose. Alternatively,
conditioning with chemotherapeutic medications such as
cyclophosphamide [36] could be used, although these have
not been tested for pretransplant conditioning of zebraﬁsh
donors.
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Figure 3: Survival of diﬀerent zebraﬁsh lines in response to radia-
tion. Kaplan-Meier survival curves are shown for four diﬀerent
zebraﬁsh strains after irradiation with a total dose of 25Gy, deliv-
ered in two equal fractions of 12.5Gy separated by 24 hours.
Twenty one ﬁsh were irradiated in each group. CG1 is a clonal
homozygousdiploidﬁshlinegeneratedbyparthenogenesis[21,38].
UDA, UXA2, and UBA are inbred zebraﬁsh lines derived from a
single mating pair of AB parents [35]. Each line was named for the
homozygous class I MHC gene at its chromosome 19 locus. The
results demonstrate 100% mortality for the CG1 ﬁsh by day 22,
and by day 37 for the UDA ﬁsh. In contrast, the UBA and UXA2
ﬁsh lines both had approximately 80% survival at 40 days after
irradiation.
8. FutureDirectionsfor Hematopoietic
Transplantation in the Zebraﬁsh
Although HSC transplantation is a commonly used treat-
ment modality for human diseases, including many malig-
nancies, blood disorders, and immune deﬁciencies, this
procedure continues to have high morbidity and mortality.
Diﬃcultiesincludeselectinganoptimallymatchedallogeneic
donor, prolonged immune suppression with susceptibility
to deadly infections, delayed and/or incomplete immune
reconstitution,andmaximizingthegraft-versus-tumoreﬀect
while minimizing graft-versus-host disease. A zebraﬁsh
model for hematopoietic transplantation permitting in vivo
investigation of these challenges would provide a basis to
understand the biological mechanisms involved and identify
possible solutions to address them.
8.1. Parthenogenesis to Develop Homozygous Diploid Fish
Lines. The lack of isogenic and congenic ﬁsh lines is a
serioushandicapforfuturetransplantationexperimentswith
zebraﬁsh. To overcome this barrier, gynogenetic ﬁsh lines
have been utilized in recent years to successfully transplant
liver tumors, acute lymphoblastic leukemia cells, and rhab-
domyosarcoma tumor cells into unirradiated immunolog-
ically identical adult recipients [21, 37]. Developing these
homozygous diploid clonal ﬁsh lines is labor intensive, time
consuming and ineﬃcient [38, 39]. However, once a robustAdvances in Hematology 7
line is generated, it can be used to make transgenic donors
withﬂuorochrome-labeledmarrowcells.Thesedonorscould
then be used to perform competitive HSC transplants using
immunologically identical donors and recipients. Develop-
ing a homozygous diploid ﬁsh line from casper ﬁsh would be
evenmoreuseful,astheadvantagesofanalyzingengraftment
at many time points could also be realized in the setting
of an immune-matched competitive transplant. Eﬀorts are
currently underway to generate these ﬁsh.
8.2. Minor Histocompatibility Antigens. Further work will
also be valuable to identify all the speciﬁc class I and II
genes important for histocompatibility in the zebraﬁsh,
both for a basic understanding of zebraﬁsh immunology,
as well as the implications for optimizing future transplant
experiments. When a zebraﬁsh mutant has a postulated HSC
defect, scientists need to have immune-matched recipients
to test whether marrow cells from the mutant zebraﬁsh
have ﬂawed engraftment in a competitive transplantation
assay. Without immune matching, such an assay will be
diﬃcult to interpret. The ability to immunotype any random
zebraﬁsh, and thereby select appropriately matched donors
and recipients would allow for a much quicker time frame
to perform these experiments, compared with generations
of inbreeding, which may be unsuccessful given the history
of prior attempts to generate such inbred zebraﬁsh lines.
However, even having a donor with “perfect” matching at
the MHC locus, human bone marrow transplant recipients
are still at risk for GVHD, likely due to mismatched minor
histocompatibility antigens on other chromosomes. There-
fore, identifying both major and minor histocompatibility
antigens throughout the genomes that are relevant for
transplant rejection and GVHD in the zebraﬁsh will be
criticaltoprospectivelydetermineoptimallymatcheddonors
and recipients. This information will clearly be useful for
zebraﬁsh experiments, as described above. In addition, iden-
tifying signiﬁcant minor histocompatibility antigens in the
zebraﬁsh would suggest minor histocompatibility antigens
that may also be relevant for human bone marrow trans-
plantation and GVHD. Such work may impact the selection
of human bone marrow transplant donors to minimize this
potentially devastating outcome after human BMT.
8.3. Developing a Zebraﬁsh Model for GVHD. Finally, in the
process of fully characterizing the zebraﬁsh histocompatibil-
ity genes, we expect to identify recipients with GVHD. To
date, we have observed transplant recipients that develop
severe edema and ascites resulting in ﬂaring of their scales.
Thisconditioninthezebraﬁshisgenericallytermed“dropsy”
and likely can result from a myriad of causes. We postulate
that in the setting of hematopoietic transplantation, some
of these recipient ﬁsh may have GVHD, although further
work is needed to fully characterize the “dropsy” pheno-
type after transplant and conﬁrm the pathophysiology of
this diagnosis. By characterizing the GVHD phenotype in
zebraﬁsh and developing a zebraﬁsh model of GVHD, one
could exploit the advantages of genetic and small molecule-
based screening to further characterize the pathways that
regulate GVHD. Such experiments may discern mechanisms
to minimize GVHD while maximizing the graft-versus-
leukemia eﬀect in bone marrow transplant patients.
9. Conclusion
As a model for human disease, the zebraﬁsh holds numerous
advantages. Gaining knowledge of the functional Class I and
II genes in the zebraﬁsh will enhance our understanding
of basic zebraﬁsh biology, as well as the ability to use this
versatile animal model to ask questions about tissue trans-
plantation, including hematopoietic stem cells, other normal
tissues and cancers cells. This work will likely inform mam-
malian biology, improving our understanding of human
HSCs, and has the potential to impact the treatment of
patients undergoing bone marrow transplantation.
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